K. S. Versteeg, S. Blauwhoff-Buskermolen, A. Maier, I. Konings, H. Verheul
{"title":"高龄晚期结直肠癌的多系细胞毒治疗","authors":"K. S. Versteeg, S. Blauwhoff-Buskermolen, A. Maier, I. Konings, H. Verheul","doi":"10.4172/2165-7386.1000293","DOIUrl":null,"url":null,"abstract":"Decision making in older cancer patients is challenging. We present the case of a fit 90-year old patient with advanced colorectal cancer, focusing on the dilemmas we faced during multilineage systemic treatment. Although chemotherapy can be effective and tolerable in nonagenarians, current evidence on how to identify patients who will benefit from treatment is limited.","PeriodicalId":91127,"journal":{"name":"Journal of palliative care & medicine","volume":"6 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2016-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4172/2165-7386.1000293","citationCount":"0","resultStr":"{\"title\":\"Multilineage Cytotoxic Treatment for Advanced Colorectal Cancer inNonagenarians\",\"authors\":\"K. S. Versteeg, S. Blauwhoff-Buskermolen, A. Maier, I. Konings, H. Verheul\",\"doi\":\"10.4172/2165-7386.1000293\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Decision making in older cancer patients is challenging. We present the case of a fit 90-year old patient with advanced colorectal cancer, focusing on the dilemmas we faced during multilineage systemic treatment. Although chemotherapy can be effective and tolerable in nonagenarians, current evidence on how to identify patients who will benefit from treatment is limited.\",\"PeriodicalId\":91127,\"journal\":{\"name\":\"Journal of palliative care & medicine\",\"volume\":\"6 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-12-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.4172/2165-7386.1000293\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of palliative care & medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4172/2165-7386.1000293\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of palliative care & medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2165-7386.1000293","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Multilineage Cytotoxic Treatment for Advanced Colorectal Cancer inNonagenarians
Decision making in older cancer patients is challenging. We present the case of a fit 90-year old patient with advanced colorectal cancer, focusing on the dilemmas we faced during multilineage systemic treatment. Although chemotherapy can be effective and tolerable in nonagenarians, current evidence on how to identify patients who will benefit from treatment is limited.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
